Connection

Christoph Correll to Risk Factors

This is a "connection" page, showing publications Christoph Correll has written about Risk Factors.
Connection Strength

0.089
  1. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
    View in: PubMed
    Score: 0.023
  2. Clinical risk factors for the development of tardive dyskinesia. J Neurol Sci. 2018 06 15; 389:21-27.
    View in: PubMed
    Score: 0.023
  3. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis. J Clin Psychiatry. 2017 01; 78(1):e28-e40.
    View in: PubMed
    Score: 0.021
  4. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis. Diabetes Obes Metab. 2019 02; 21(2):293-302.
    View in: PubMed
    Score: 0.006
  5. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):397-410.
    View in: PubMed
    Score: 0.006
  6. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e1035-e1046.
    View in: PubMed
    Score: 0.005
  7. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers. J Clin Psychiatry. 2017 Jul; 78(7):e744-e781.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.